WHO ICTRP trial
PROSPECTIVE STUDY ?IBDISC?: Regeneration and Immunity in patients affected by…
EUCTR2008-008285-12-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2008-008285-12-IT |
|---|---|
| Public title | PROSPECTIVE STUDY ?IBDISC?: Regeneration and Immunity in patients affected by IBD undergoing immunomodulatory treatment and adjuvant role of G-CSF and/or plasmapheresis (Inflammatory Bowel Diseases Immunity and Stem Cells) - IBDISC |
| Scientific title | PROSPECTIVE STUDY ?IBDISC?: Regeneration and Immunity in patients affected by IBD undergoing immunomodulatory treatment and adjuvant role of G-CSF and/or plasmapheresis (Inflammatory Bowel Diseases Immunity and Stem Cells) - IBDISC |
| Primary sponsor | POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Inflammatory bowel disease MedDRA version: 9.1 Level: PT Classification code 10011401 MedDRA version: 9.1 Level: LLT Classification code 10045282 |
| Interventions | Trade Name: GRANOCYTE 34 Pharmaceutical Form: Solution for injection INN or Proposed INN: Lenograstim Concentration unit: µg/kg microgram(s)/kilogram Concentration type: equal Concentration number: 10- |
| Registration date | Apr 14, 2009 |
| Secondary IDs | 1655/08 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: